Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xuanfei Zhisou Heji is a standardized traditional Chinese medicine (TCM) preparation developed by Gansu Pu'an Pharmaceutical Co., Ltd. It is a complex herbal formulation containing eight active botanical ingredients: *Aster tataricus*, *Stemona sessilifolia*, *Platycodon grandiflorus*, *Citrus reticulata*, *Houttuynia cordata*, *Papaver somniferum* husk, *Glycyrrhiza uralensis*, and *Ephedra sinica*. The preparation is indicated for the treatment of respiratory conditions, including post-infectious cough, cough variant asthma, and bronchitis, by dispelling wind, promoting lung circulation, and resolving phlegm. It has also been investigated for managing cough symptoms associated with COVID-19.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xuanfei Zhisou Heji.